Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 20.33 Billion JPY | 1.58% |
| 2022 | 20.02 Billion JPY | 1.56% |
| 2021 | 19.71 Billion JPY | 2.66% |
| 2020 | 19.2 Billion JPY | 0.34% |
| 2019 | 19.13 Billion JPY | 6.19% |
| 2018 | 18.02 Billion JPY | 13.62% |
| 2017 | 15.86 Billion JPY | 3.46% |
| 2016 | 15.33 Billion JPY | 13.86% |
| 2015 | 13.46 Billion JPY | 8.18% |
| 2014 | 12.44 Billion JPY | 1.15% |
| 2013 | 12.3 Billion JPY | 1.08% |
| 2012 | 12.17 Billion JPY | 3.84% |
| 2011 | 11.72 Billion JPY | 25.61% |
| 2010 | 9.33 Billion JPY | 0.93% |
| 2009 | 9.24 Billion JPY | 4.47% |
| 2008 | 8.85 Billion JPY | 4.1% |
| 2007 | 8.5 Billion JPY | 2.49% |
| 2006 | 8.29 Billion JPY | 11.01% |
| 2005 | 7.47 Billion JPY | 11.05% |
| 2004 | 6.73 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 976 Million JPY | -79.83% |
| 2024 Q2 | 460 Million JPY | -52.87% |
| 2023 Q2 | 4.25 Billion JPY | 17.96% |
| 2023 FY | 20.33 Billion JPY | 1.58% |
| 2023 Q3 | 7.63 Billion JPY | 79.37% |
| 2023 Q4 | 4.84 Billion JPY | -36.6% |
| 2023 Q1 | 3.6 Billion JPY | -34.66% |
| 2022 FY | 20.02 Billion JPY | 1.56% |
| 2022 Q2 | 4.22 Billion JPY | 21.71% |
| 2022 Q1 | 3.47 Billion JPY | -28.13% |
| 2022 Q4 | 5.52 Billion JPY | -18.79% |
| 2022 Q3 | 6.8 Billion JPY | 60.87% |
| 2021 FY | 19.71 Billion JPY | 2.66% |
| 2021 Q4 | 4.83 Billion JPY | -30.99% |
| 2021 Q1 | 3.62 Billion JPY | -8.08% |
| 2021 Q2 | 4.25 Billion JPY | 17.23% |
| 2021 Q3 | 7 Billion JPY | 64.64% |
| 2020 FY | 19.2 Billion JPY | 0.34% |
| 2020 Q4 | 3.94 Billion JPY | -43.93% |
| 2020 Q3 | 7.04 Billion JPY | 57.28% |
| 2020 Q2 | 4.47 Billion JPY | 19.62% |
| 2020 Q1 | 3.74 Billion JPY | -3.9% |
| 2019 FY | 19.13 Billion JPY | 6.19% |
| 2019 Q4 | 3.89 Billion JPY | -44.71% |
| 2019 Q3 | 7.04 Billion JPY | 55.85% |
| 2019 Q2 | 4.51 Billion JPY | 22.7% |
| 2019 Q1 | 3.68 Billion JPY | -8.25% |
| 2018 Q1 | 3.82 Billion JPY | -7.32% |
| 2018 Q2 | 3.8 Billion JPY | -0.34% |
| 2018 FY | 18.02 Billion JPY | 13.62% |
| 2018 Q4 | 4.01 Billion JPY | -37.08% |
| 2018 Q3 | 6.38 Billion JPY | 67.54% |
| 2017 Q4 | 4.12 Billion JPY | -12.33% |
| 2017 FY | 15.86 Billion JPY | 3.46% |
| 2017 Q1 | 3.45 Billion JPY | 0.0% |
| 2017 Q2 | 3.58 Billion JPY | 3.68% |
| 2017 Q3 | 4.7 Billion JPY | 31.3% |
| 2016 FY | 15.33 Billion JPY | 13.86% |
| 2016 Q2 | 5.21 Billion JPY | 415.71% |
| 2016 Q3 | 2.89 Billion JPY | -44.63% |
| 2016 Q1 | 1.01 Billion JPY | -84.29% |
| 2015 FY | 13.46 Billion JPY | 8.18% |
| 2015 Q1 | 1.77 Billion JPY | -65.96% |
| 2015 Q4 | 6.44 Billion JPY | 105.75% |
| 2015 Q2 | 2.88 Billion JPY | 62.39% |
| 2015 Q3 | 3.13 Billion JPY | 8.53% |
| 2014 Q4 | 5.21 Billion JPY | 71.81% |
| 2014 Q2 | 2.41 Billion JPY | 17.44% |
| 2014 FY | 12.44 Billion JPY | 1.15% |
| 2014 Q3 | 3.03 Billion JPY | 25.65% |
| 2014 Q1 | 2.05 Billion JPY | -52.09% |
| 2013 Q3 | 2.98 Billion JPY | 0.84% |
| 2013 Q4 | 4.29 Billion JPY | 43.73% |
| 2013 Q2 | 2.96 Billion JPY | 420.0% |
| 2013 Q1 | 570 Million JPY | -87.29% |
| 2013 FY | 12.3 Billion JPY | 1.08% |
| 2012 Q1 | 2.25 Billion JPY | -32.2% |
| 2012 Q2 | 3.78 Billion JPY | 67.91% |
| 2012 Q4 | 4.48 Billion JPY | 34.43% |
| 2012 Q3 | 3.33 Billion JPY | -11.79% |
| 2012 FY | 12.17 Billion JPY | 3.84% |
| 2011 Q2 | 3.4 Billion JPY | 613.9% |
| 2011 Q4 | 3.32 Billion JPY | 20.92% |
| 2011 Q3 | 2.74 Billion JPY | -19.22% |
| 2011 FY | 11.72 Billion JPY | 25.61% |
| 2011 Q1 | -662 Million JPY | -117.78% |
| 2010 Q1 | 187 Million JPY | -94.94% |
| 2010 Q2 | 2.73 Billion JPY | 1361.5% |
| 2010 Q3 | 3.54 Billion JPY | 29.56% |
| 2010 FY | 9.33 Billion JPY | 0.93% |
| 2010 Q4 | 3.72 Billion JPY | 5.14% |
| 2009 Q1 | 71 Million JPY | -98.14% |
| 2009 Q3 | 2.64 Billion JPY | -2.65% |
| 2009 Q4 | 3.69 Billion JPY | 39.85% |
| 2009 FY | 9.24 Billion JPY | 4.47% |
| 2009 Q2 | 2.71 Billion JPY | 3726.76% |
| 2008 Q4 | 3.81 Billion JPY | 61.12% |
| 2008 FY | 8.85 Billion JPY | 4.1% |
| 2008 Q3 | 2.36 Billion JPY | 0.0% |
| 2007 FY | 8.5 Billion JPY | 2.49% |
| 2006 FY | 8.29 Billion JPY | 11.01% |
| 2005 FY | 7.47 Billion JPY | 11.05% |
| 2004 FY | 6.73 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -90.63 Thousand USD | 22439059.807% |
| Bruush Oral Care Inc. | -8.76 Million USD | 232129.335% |
| CCA Industries, Inc. | -422.86 Thousand USD | 4809661.421% |
| DSwiss, Inc. | -49.53 Thousand USD | 41057937.892% |
| EOS, Inc. | -627.15 Thousand USD | 3243003.657% |
| Greyson International, Inc. | -75.94 Thousand USD | 26780711.775% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -16948233.333% |
| Infusion Brands International, Inc. | -6.94 Million USD | 292968.863% |
| Mandom Corporation | 17.18 Million USD | -118248.725% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -597.89 Thousand USD | 3401706.305% |
| Oliveda International, Inc. | -1.3 Million USD | 1553144.274% |
| PacificHealth Laboratories, Inc. | -486.31 Thousand USD | 4182197.464% |
| Prosperous Future Holdings Limited | -4.96 Million USD | 409953.657% |
| PURE Bioscience, Inc. | -3.35 Million USD | 607204.478% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -2.38 Million USD | 853762.632% |
| Sentient Brands Holdings Inc. | -477.73 Thousand USD | 4257280.774% |
| Sunset Capital Assets, Inc. | -252.33 Thousand USD | 8059924.521% |
| The Stephan Co. | -83 Thousand USD | 24503714.458% |
| Turner Valley Oil & Gas, Inc. | -300.05 Thousand USD | 6778100.327% |
| Winning Brands Corporation | -395.48 Thousand USD | 5142685.503% |
| Warpaint London PLC | 17.69 Million USD | -114846.641% |
| Zoono Group Limited | -5.6 Million USD | 362990.074% |
| Zurvita Holdings, Inc. | -435.23 Thousand USD | 4673010.08% |